Clinical Trials Browser

Phase 2 × INDUSTRY × Genital Diseases, Female × Clear all

Adnexal Diseases, Carcinoma, Endocrine System Diseases, Endocrine Gland Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Genital Neoplasms, Female, Gonadal Disorders, Neoplasm Metastasis, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms, Female Urogenital Diseases

NCT02139267 2017-07-12

Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia

Phase 2 Completed

72 enrolled

Gynecologic

Uterine Cervical Dysplasia, Genital Diseases, Female, Neoplasms, Uterine Diseases, Papillomavirus Infections

NCT01576380 2017-02-27

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

Phase 2 Completed

11 enrolled

Gastrointestinal

Carcinoma, Adenocarcinoma, Scirrhous, Genital Diseases, Female, Linitis Plastica, Neoplasms, Neoplasms by Site, Stomach Diseases, Stomach Neoplasms

NCT01379534 2015-05-20

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Phase 2 Completed

53 enrolled 10 charts

Gynecologic

Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT00050414 2013-01-10

A Study of Trabectedin in Patients With Advanced Ovarian Cancer

Phase 2 Completed

147 enrolled

Gynecologic

Adnexal Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms

Clinical Trials

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

A Study of Trabectedin in Patients With Advanced Ovarian Cancer